| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $11.69B | $11.20B | $11.16B |
| YoY Revenue Growth % | +4.4% | +0.3% | — |
| Gross Profit | $3.92B | $5.30B | — |
| Gross Margin % | 33.5% | 47.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.44B | $2.90B | $2.56B |
| Operating Margin % | 12.3% | 25.9% | 22.9% |
| Net Income (GAAP) | $883.3M | $2.22B | $1.86B |
| EBITDA (Normalized) | $1.81B | $3.38B | $2.96B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.28B | $2.53B | $2.32B |
| Capital Expenditures (CapEx) | $454.6M | $605.9M | $502.4M |
| Free Cash Flow (FCF) | $1.82B | $1.93B | $1.82B |
| FCF Margin % | 15.6% | 17.2% | 16.3% |
| Return on Invested Capital (ROIC %) | 14.6% | 35.3% | 18.9% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $4.68B | $3.19B | $4.14B |
| Total Stockholders' Equity | $4.64B | $4.71B | $8.50B |